[Federal Register Volume 88, Number 106 (Friday, June 2, 2023)]
[Notices]
[Page 36275]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-11779]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[B-9-2023]


Foreign-Trade Zone (FTZ) 46; Authorization of Production 
Activity; Patheon Pharmaceuticals Inc.; (Pharmaceutical Products); 
Cincinnati, Ohio

    On January 27, 2023, Patheon Pharmaceuticals Inc. submitted a 
notification of proposed production activity to the FTZ Board for its 
facilities within Subzone 46K, in Cincinnati, Ohio.
    The notification was processed in accordance with the regulations 
of the FTZ Board (15 CFR part 400), including notice in the Federal 
Register inviting public comment (88 FR 7394, February 3, 2023). On May 
30, 2023, the applicant was notified of the FTZ Board's decision that 
no further review of the activity is warranted at this time. The 
production activity described in the notification was authorized, 
subject to the FTZ Act and the FTZ Board's regulations, including 
section 400.14.

    Dated: May 30, 2023.
Elizabeth Whiteman,
Executive Secretary.
[FR Doc. 2023-11779 Filed 6-1-23; 8:45 am]
BILLING CODE 3510-DS-P